Can duloxetine (Cymbalta) cause ataxia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Duloxetine Cause Ataxia?

Ataxia is not a recognized or documented adverse effect of duloxetine based on current clinical evidence and guidelines. If a patient on duloxetine presents with ataxia, you must investigate alternative causes rather than attributing it to the medication.

Common Adverse Effects of Duloxetine

The established side effect profile of duloxetine does not include ataxia. The documented adverse effects are:

  • Gastrointestinal and neurological symptoms: Nausea, dry mouth, headache, constipation, dizziness, decreased appetite, somnolence, and fatigue are the most common 1, 2
  • Severity: These effects are typically mild to moderate and most prominent in the first week of treatment 1
  • Cardiovascular effects: Duloxetine can increase systolic and diastolic blood pressure and heart rate 1
  • Rare serious effects: Hepatic failure, severe skin reactions, suicidal thinking, and serotonin syndrome may occur but are uncommon 1, 2

Clinical Approach When Ataxia Develops

When a patient on duloxetine presents with ataxia, you must systematically evaluate other causes:

1. Review All Concurrent Medications

  • Drug interactions: Duloxetine is a moderate CYP2D6 inhibitor, which could increase levels of other medications that cause ataxia 2
  • CNS depressants: Benzodiazepines, antipsychotics, or other sedatives are well-documented causes of ataxia and dyscoordination 2
  • Anticholinergics: These commonly cause neurological side effects including coordination problems 2

2. Perform Neurological Evaluation

  • Rule out stroke: New-onset ataxia warrants immediate evaluation for cerebrovascular events, particularly posterior circulation strokes 2
  • Assess for neurodegenerative disease: Consider structural brain pathology or progressive neurological conditions 2
  • Examine for cerebellar pathology: Mass lesions, paraneoplastic syndromes, or inflammatory conditions affecting the cerebellum should be excluded 3

3. Consider Toxic and Metabolic Causes

  • Substance abuse: Chronic ethanol abuse, methanol toxicity, heroin use, and solvent abuse can all cause cerebellar atrophy and ataxia 3
  • Medication toxicity: Metronidazole, gabapentin (which can cause isolated ataxia as an idiosyncratic reaction), and other medications have documented associations with ataxia 3, 4
  • Nutritional deficiencies: Vitamin E deficiency can cause cerebellar atrophy and ataxia 3

4. Evaluate for Systemic Conditions

  • Infectious causes: Bacterial cerebellitis, acute disseminated encephalomyelitis, or Miller Fisher syndrome (a Guillain-Barré variant) can present with ataxia 3
  • Autoimmune disorders: Vasculitides such as neuro-Behçet disease and demyelinating diseases like multiple sclerosis may cause ataxia 3
  • Paraneoplastic syndromes: Subacute cerebellar degeneration associated with malignancy presents with gait and limb ataxia 3

Key Clinical Pitfall to Avoid

Do not attribute ataxia to duloxetine without thoroughly investigating other causes, as this is not a recognized adverse effect of the medication 2. Misattribution could delay diagnosis of serious underlying conditions such as stroke, mass lesions, or toxic exposures that require urgent intervention.

Contrast with Other Medications

Unlike duloxetine, gabapentin—another medication used for neuropathic pain—has documented cases of isolated severe ataxia as an idiosyncratic adverse reaction, even at low doses 4. This highlights that ataxia is a recognized side effect of some neurological medications but not duloxetine.

References

Guideline

Duloxetine Scheduling and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adverse Effects of Duloxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.